DJIA 17,789.72 70.72 0.40%
NASDAQ 4,708.39 6.52 0.14%
S&P 500 2,059.05 6.30 0.31%
market minute promo

Exelixis (NASDAQ: EXEL)

company name or ticker

Time to Fall Back in Love With Exelixis Inc.?

Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver

Roche skin cancer drug meets main goal in combination study

Exelixis Shares Move 12% On Phase 3 Data

US STOCKS-Futures higher on M&A after down week

Why Exelixis Inc. Stock Soared

Melanoma Treatment Cobimetinib Helps Prolong Survival in Phase III Trial

Roche Presents Encouraging Data on Cobimetinib

High Volume Stocks for Jul-14 At The Close

3 Crashing Biotechs: Is 1 a Buy?